tacforius
teva b.v. - tacrolimus monohidrat - liver transplantation; kidney transplantation - imunosupresoare - profilaxia respingerii transplantului la adulții adulți din rinichi sau ficat. tratamentul respingerii alogrefei rezistent la tratamentul cu alte medicamente imunosupresoare la pacienții adulți.
kisplyx
eisai gmbh - lenvatinib mesilate - carcinomul, celula renală - agenți antineoplazici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
vivace 10 mg
actavis ltd. - malta - ramiprilum - compr. - 10 mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei
vivace 2,5 mg
actavis ltd. - malta - ramiprilum - compr. - 2,5 mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei
vivace 5 mg
actavis ltd. - malta - ramiprilum - compr. - 5 mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei
afinitor 10 mg
novartis pharma gmbh - germania - everolimus - compr. - 10 mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
afinitor 5 mg
novartis pharma gmbh - germania - everolimus - compr. - 5 mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
votubia
novartis pharma gmbh - germania - everolimus - compr. - 10mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
votubia
novartis pharma gmbh - germania - everolimus - compr. - 2,5 mg - inhibitori de protein-kinaza inhibitor selectiv al mtor
votubia
novartis pharma gmbh - germania - everolimus - compr. - 5mg - inhibitori de protein-kinaza inhibitor selectiv al mtor